Summit Therapeutics (SMMT) Return on Capital Employed Growth (1y) (2021 - 2024)
Summit Therapeutics (SMMT) Return on Capital Employed Growth (1y) (2021 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - | -3,457.00 |
| 10 | Summit Therapeutics | 10.46 Bn | 9.77 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 26,748.00 |
| Sep 30, 2024 | 46,589.00 |
| Jun 30, 2024 | 11,880.00 |
| Mar 31, 2024 | 6,377.00 |
| Dec 31, 2023 | -30,092.00 |
| Sep 30, 2023 | -44,848.00 |
| Jun 30, 2023 | -16,359.00 |
| Mar 31, 2023 | -3,364.00 |
| Dec 31, 2022 | 7,091.00 |
| Sep 30, 2022 | -879.00 |
| Jun 30, 2022 | -3,139.00 |
| Mar 31, 2022 | 2,591.00 |
| Dec 31, 2021 | 1,774.00 |